ERICA WALL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health SCHENECTADY, NY NPI 1083152136
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health NY Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$780.05
- Category: General Payments
- Program years: PY2023–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $414.15 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $414.15 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $149.80 | 3 |
| Axsome Therapeutics, Inc. | $141.47 | 4 |
| Supernus Pharmaceuticals, Inc. | $122.88 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1147888187 | Supernus Pharmaceuticals, Inc. | $122.88 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148358112 | Axsome Therapeutics, Inc. | $4.12 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148358114 | Axsome Therapeutics, Inc. | $14.70 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148358116 | Axsome Therapeutics, Inc. | $7.12 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148358118 | Axsome Therapeutics, Inc. | $115.53 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150925889 | Neurocrine Biosciences, Inc. | $95.06 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150927997 | Neurocrine Biosciences, Inc. | $50.84 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151025055 | Neurocrine Biosciences, Inc. | $3.90 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.